Total Payments
$4,141
2024 Payments
$703.81
Companies
20
Transactions
317
Medicare Patients
1,597
Medicare Billing
$99,522
Payment Breakdown by Category
Food & Beverage$4,001 (96.6%)
Education$139.40 (3.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,001 | 313 | 96.6% |
| Education | $139.40 | 4 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,266 | 146 | $0 (2024) |
| ABBVIE INC. | $948.24 | 66 | $0 (2024) |
| Janssen Biotech, Inc. | $445.78 | 27 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $330.71 | 18 | $0 (2024) |
| Celgene Corporation | $188.51 | 11 | $0 (2024) |
| Ardelyx, Inc. | $184.94 | 10 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $143.50 | 6 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $105.31 | 6 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $102.63 | 5 | $0 (2024) |
| Gilead Sciences, Inc. | $94.45 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $703.81 | 51 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($222.99) |
| 2023 | $1,003 | 78 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($290.21) |
| 2022 | $1,409 | 106 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($395.30) |
| 2021 | $1,025 | 82 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($357.34) |
All Payment Transactions
317 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: IMMUNOLOGY | ||||||
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $8.26 | General |
| Category: Gastroenterology | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $9.60 | General |
| Category: Gastroenterology | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $1.22 | General |
| Category: Gastroenterology | ||||||
| 12/02/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: Gastroenterology | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $3.94 | General |
| Category: Gastroenterology | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $9.24 | General |
| Category: Gastroenterology | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $10.67 | General |
| Category: Gastroenterology | ||||||
| 10/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $4.77 | General |
| Category: Gastroenterology | ||||||
| 09/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN, PLENVU | Food and Beverage | In-kind items and services | $3.20 | General |
| Category: Gastroenterology | ||||||
| 09/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Gastroenterology | ||||||
| 08/29/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/29/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $1.88 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/14/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN, PLENVU | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: Gastroenterology | ||||||
| 08/13/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.84 | General |
| 08/07/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN, PLENVU | Food and Beverage | In-kind items and services | $5.72 | General |
| Category: Gastroenterology | ||||||
| 08/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $7.97 | General |
| Category: Gastroenterology | ||||||
| 07/25/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $13.54 | General |
| Category: Neuroscience | ||||||
| 07/17/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Gastroenterology | ||||||
| 07/17/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.38 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 400 | 497 | $59,477 | $28,326 |
| 2022 | 2 | 370 | 463 | $53,561 | $23,870 |
| 2021 | 4 | 398 | 487 | $54,037 | $25,272 |
| 2020 | 6 | 429 | 493 | $56,289 | $22,054 |
Total Patients
1,597
Total Services
1,940
Medicare Billing
$99,522
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 297 | 392 | $42,910 | $20,837 | 48.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 70 | 70 | $10,967 | $4,528 | 41.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 33 | 35 | $5,600 | $2,961 | 52.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 313 | 406 | $44,555 | $20,554 | 46.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 57 | 57 | $9,006 | $3,316 | 36.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 323 | 411 | $45,035 | $21,960 | 48.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 28 | 28 | $4,424 | $1,665 | 37.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 14 | 15 | $2,400 | $1,050 | 43.8% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 33 | 33 | $2,178 | $596.17 | 27.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 268 | 327 | $36,270 | $14,278 | 39.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 38 | 39 | $6,316 | $2,564 | 40.6% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 31 | 31 | $5,735 | $1,827 | 31.9% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 62 | 65 | $3,411 | $1,752 | 51.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 18 | 19 | $1,665 | $904.34 | 54.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 12 | 12 | $2,892 | $728.70 | 25.2% |
About Brandee Burley
Brandee Burley is a Physician Assistant healthcare provider based in Geneva, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2014. The National Provider Identifier (NPI) number assigned to this provider is 1184037244.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Brandee Burley has received a total of $4,141 in payments from pharmaceutical and medical device companies, with $703.81 received in 2024. These payments were reported across 317 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($4,001).
As a Medicare-enrolled provider, Burley has provided services to 1,597 Medicare beneficiaries, totaling 1,940 services with total Medicare billing of $99,522. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Geneva, NY
- Active Since 06/06/2014
- Last Updated 10/31/2019
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1184037244
Products in Payments
- XIFAXAN (Drug) $1,186
- STELARA (Biological) $445.78
- ENTYVIO (Biological) $270.46
- HUMIRA (Biological) $228.91
- RINVOQ (Biological) $212.93
- ZEPOSIA (Drug) $188.51
- IBSRELA (Drug) $184.94
- LINZESS (Drug) $150.80
- DUPIXENT (Biological) $143.50
- MAVYRET (Drug) $121.86
- SKYRIZI (Biological) $105.14
- Linzess (Drug) $102.63
- TRULANCE (Drug) $80.19
- CREON (Drug) $68.46
- MOTEGRITY (Drug) $60.25
- VIBERZI (Drug) $60.14
- ZENPEP (Drug) $51.40
- CIMZIA (Drug) $44.65
- VOQUEZNA (Drug) $43.72
- REBYOTA (Biological) $41.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Geneva
Cassie Mandala, Pa-C, PA-C
Physician Assistant — Payments: $52,341
Physician Assistant $52,341
Zachary Andor, Pa-C, PA-C
Physician Assistant — Payments: $6,462
Physician Assistant $6,462
Meghan Fadeley, Pa, PA
Physician Assistant — Payments: $5,214
Physician Assistant $5,214
Angela Lang, Pa-C, PA-C
Physician Assistant — Payments: $1,954
Physician Assistant $1,954
Mr. Philipp Ewert, Pa, PA
Physician Assistant — Payments: $1,715
Physician Assistant $1,715
Dean Bieniak, Pa-C, PA-C
Physician Assistant — Payments: $1,589
Physician Assistant $1,589